F-16438s, novel binding inhibitors of CD44 and hyaluronic acid: I. Establishment of an assay method and biological activity

Journal of Antibiotics

Volumn 59, Issue 12, 2006, Pages 770-776

  Harada, Hosami ^a   Nakata, Tomoko ^a   Hirota Takahata, Yuki ^a   Tanaka, Isshin ^a   Nakajima, Mutsuo ^a   Takahashi, Masaaki ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Binding inhibitor; CD44; F 16438; Hyaluronic acid; Screening method

Indexed keywords

CELL SURFACE RECEPTOR; CELL SURFACE RECEPTOR CD44; F 16438; FUNGAL PROTEIN; HYALURONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DETERMINATION; DRUG ISOLATION; FUNGUS; GLOEOPORUS DICHROUS; HUMAN; HUMAN CELL; IC 50; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTIGENS, CD44; CELL LINE; ENDOCYTOSIS; HUMANS; HYALURONIC ACID; MANNOSIDES; POLYPORALES; SALICYLATES;

FUNGI; GLOEOPORUS DICHROUS;

EID: 33846834197     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2006.101     Document Type: Article

References (36)

1. Toole BP. Proteoglycans and hyaluronan in morphogenesis and differentiation. In Cell biology of extracellular matrix. Ed., ED. Hay, pp. 61-92, Plenum Press, New York (1991)
2. Toole BP. Hyaluronan in morphogenesis. Semin Cell Dev Biol 12: 79-87 (2001)
3. Longaker MT, Chiu ES, Adzick NS, Stern M, Harrison MR, Stern R. Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg 213: 292-296 (1991)
4. Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 119: 219-234 (1986)
5. de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK. Strong SA. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 163: 121-133 (2003)
6. Majors AK, Austin RC, de la Motte CA, Pyeritz RE, Hascall VC, Kessler SP, Sen G, Strong SA. Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion. J Biol Chem 278: 47223-47231 (2003)
7. Toole BP. Hyaluronan promotes the malignant phenotype. Glycobiology 12: 37-42 (2002)
8. Toole BP, Hascall VC. Hyaluronan and tumor growth. Am J Pathol 161: 745-747 (2002)
9. Ascher B, Cerceau M, Baspeyras M, Rossi B. Soft tissue filling with hyaluronic acid. Ann Chir Plast Esthet 49: 465-485 (2004)
10. Abatangelo G, O'Regan M. Hyaluronan: biological role and function in articular joints. Eur J Rheumatol Inflamm 15: 9-16 (1995)
11. Dahl LB, Dahl IMS, Engström-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44: 817-822 (1985)
12. Ghosh P. The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of the synovial fluid. Clin Exp Rheumatol 12: 75-82 (1994)
13. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 54: 271-335 (1993)
14. Picker LJ, Nakache M, Butcher EC. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 109: 927-937 (1989)
15. Bourguignon LY, Lokeshwar VB, He J, Chen X, Bourguignon GJ. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin. Mol Cell Biol 12: 4464-4471 (1992)
16. Zhu D, Bourguignon LY. Overexpression of CD44 in pl85(neu)-transfected NIH3T3 cells promotes an upregulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion. Oncogene 12: 2309-2314 (1996)
17. Brown TA, Bouchard T, St John T, Wayner E, Carter WG. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 113: 207-221 (1991)
18. Grover J, Roughley PJ. Expression of cell-surface proteoglycan mRNA by human articular chondrocytes. Biochem J 309: 963-968 (1995)
19. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313 (1990)
20. Miyake K, Underhill CB, Lesley J, Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172: 69-75 (1990)
21. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate bearing cells. EMBO J 10: 343-348 (1991)
22. Shimizu Y, Van Seventer GA, Siraganian R, Wahl L, Shaw S. Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 143: 2457-2463 (1989)
23. Lesley J, Howes N, Perschl A, Hyman R. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J Exp Med 180: 383-387 (1994)
24. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24 (1991)
25. Sy MS, Guo YJ, Stamenkovic I. Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174: 859-866 (1991)
26. Udabage L, Brownlee GR, Nilsson SK, Brown TJ. The overexpression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res 310: 205-217 (2005)
27. Chow G, Knudson CB, Homandberg G, Knudson W. Increased expression of CD44 in bovine articular chondrocytes by catabolic cellular mediators. J Biol Chem 270: 27734-27741 (1995)
28. Culty M, Nguyen HA, Underhill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 116: 1055-1062 (1992)
29. Hua Q, Knudson CB, Knudson W. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci 106: 365-375 (1993)
30. Tammi R, Rilla K, Pienimaki JP, MacCallum DK, Hogg M, Luukkonen M, Hascall VC, Tammi M. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem 276: 35111-35122 (2001)
31. Hirota-Takahara Y, Harada H, Tanaka I, Nakata T, Nakajima M, Takahashi M. F-16438s, novel binding inhibitors of and hyaluronic acid CD44. II. Producing organism, fermentation, isolation, physico-chemical properties and structural elucidation. J Antibiot 59: 770-776
32. de Belder AN, Wik KO. Preparation and properties of fluorescein-labelled hyaluronate. Carbohydr Res 44: 251-257 (1975)
33. Underhill CB, Toole BP. Physical characteristics of hyaluronate binding to the surface of simian virus 40-transformed 3T3 cells. J Biol Chem 255: 4544-4549 (1980)
34. Underhill CB, Green SJ, Comoglio PM, Tarone G. The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity. J Biol Chem 262: 13142-13146 (1987)
35. Underhill CB, Chi-Rosso G, Toole BP. Effects of detergent solubilization on the hyaluronate-binding protein from membranes of simian virus 40-transformed 3T3 cells. J Biol Chem 258: 8086-8091 (1983)
36. Weber W, Schu P, Anke T, Velten R, Steglich W. Caloporoside, a new inhibitor of phospholipases C from Caloporus dichrous (Fr.) Ryv. J Antibiot 47: 1188-1194 (1994)